Mindray Medical International Limited (MR): Today's Featured Health Care Winner

Mindray Medical International ( MR) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 1.8%. By the end of trading, Mindray Medical International rose 21 cents (0.8%) to $27.30 on light volume. Throughout the day, 351,253 shares of Mindray Medical International exchanged hands as compared to its average daily volume of 611,500 shares. The stock ranged in a price between $26.62-$27.57 after having opened the day at $26.81 as compared to the previous trading day's close of $27.09. Other companies within the Health Care sector that increased today were: Momenta Pharmaceuticals Inc ( MNTA), up 20.9%, Cormedix Inc ( CRMD), up 16.7%, Zalicus Inc ( ZLCS), up 15.8%, and Complete Genomics Inc ( GNOM), up 14%.

Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., develops, manufactures, and markets medical devices worldwide. Mindray Medical International has a market cap of $2.9 billion and is part of the health services industry. The company has a P/E ratio of 19.6, above the average health services industry P/E ratio of 18.9 and above the S&P 500 P/E ratio of 17.7. Shares are down 0.3% year to date as of the close of trading on Friday.

TheStreet Ratings rates Mindray Medical International as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and disappointing return on equity.

On the negative front, NPS Pharmaceuticals Inc ( NPSP), down 33.4%, Integra LifeSciences Holdings Inc ( IART), down 16.4%, BioMimetic Therapeutics Inc ( BMTI), down 11.7%, and BioSpecifics Technologies Corporation ( BSTC), down 10.9%, were all losers within the health care sector with Valeant Pharmaceuticals International Inc ( VRX) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern

Trump Tariff Threat, Deutsche Bank, Elon Musk and Apple - 5 Things You Must Know

Trump Tariff Threat, Deutsche Bank, Elon Musk and Apple - 5 Things You Must Know

Automakers Slump as Trump Launches National Security Probe into US Car Imports

Automakers Slump as Trump Launches National Security Probe into US Car Imports

Deutsche Bank Confirms Massive Job Cuts as New CEO Christian Sewing Plants Flag

Deutsche Bank Confirms Massive Job Cuts as New CEO Christian Sewing Plants Flag

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market